Dr. Jay Tong
Founder and Chairman of the Board
Jay Tong founded AllCells, LLC in 1998 and served as the company’s President & CEO until 2018 when he became Chairman. While working as a Research Scientist at Novartis-Systemix (Palo Alto, CA) in the 1990s, Dr. Tong recognized an industry need for a readily available commercial source of hematologic tissue such as bone marrow, cord & peripheral blood, and purified hematology & immunology primary cell types needed to support scientific research, drug discovery and development. Jay earned his M.D. from Suzhou Medical College in China, and completed graduate studies in Hematology at Henan University at Zheng Zhou. He later completed his Hematology Fellowship at the prestigious Genoa Medical School in Italy, a world leader in bone marrow transplantation. Additional post-doctoral training took Dr. Tong to Dr. Ronald Hoffman’s Lab at Indiana University Medical School at Indianapolis. Dr. Tong has published over thirty (30) peer reviewed papers relating to stem cell purification, ex vivo expansion, gene transduction, and hematopoietic stem cell transplantation.
Don is a seasoned business executive who is highly experienced in sales, marketing, finance, supply chain and technology. Don has been part of the AllCell’s team since early 2016. He has been especially instrumental in leading the AllCells 2.0 initiative which has involved optimizing business processes, leveraging technology, increasing teamwork and collaboration and developing AllCell’s sales and marketing strategies. Don lead the implementation of AllCell’s new enterprise platform that has greatly enhanced AllCell’s capabilities to deliver product, manage the business and serve our customers. Don has led teams from angel startups to large fortune 500 sized companies.
Ted Parenti, Director of Finance, joined AllCells LLC in May 2016. Mr. Parenti brings to AllCells extensive experience in cost accounting, capital investment and budget, and forecast/analysis using ERP systems. Ted has primary responsibility for leading the company’s accounting control, financial reporting, and forecasting processes.
Prior to joining AllCells Mr. Parenti served as Industrial Controller with Bio-Rad Laboratories, Inc. where he was responsible for financial control covering multiple operational sites within Bio-Rad’s life science division. Ted has held several financial management positions including Cost Accounting Manager at Peet’s Coffee & Tea, Cost Manager with The Clorox Company, Regional Finance Manager with General Mills Operations, Inc., and others.
Rob Frankenberg PhD, PMP, CPIM, CSCP
VP Supply Chain
Rob Frankenberg joined AllCells’ executive team June 20, 2016. Rob brings to AllCells 24+ years global experience in (1) processing of recombinant biologics, chemicals and diagnostic reagents; (2) optimizing operations, while meeting safety, cGMP and ISO regulations; (3) resolution of complex discrepancies to regulatory expectations through root cause analysis and continuous improvement; (4) providing technical stewardship of operations through management of technology and statistical process control; (5) co-inventing of commercial purification processes; (6) effectiveness in influence management of multiple global contract manufacturing and contract research organizations.
Previously Rob was GMP Operations Manager at Bio-Rad Laboratories, accountable for the operational leadership of Bio-Rad’s GMP clinical diagnostics consumables manufacturing operation representing >$250M in annual sales and a production team of 29 team members and 3 supervisors. He was responsible for operations management within SAP, optimization of resource utilization, project management of continuous improvement, facility startup and expansion initiatives and capital projects. Rob holds Bachelor of Science in Biochemistry (UC Davis), a Ph.D. in Bioengineering (UCSF and UC Berkeley) with a Certificate in Management of Technology (Haas School Of Business), a Project Management Professional (PMP, PMI) Certification, a certification in Production and Inventory Management (CPIM, APICS) and a certification as a Supply Chain Professional (CSCP, APICS).
Timothy C. Fong, PhD, MBA
VP Science & Bio Technology
Tim Fong joined the executive team March 16, 2017. Tim has over 20 years of biotech industry experience with broad expertise in therapeutic drug discovery and development. Tim has led teams in discovery research, preclinical studies, product characterization, and GMP manufacturing process development in several platform technologies, including cell and gene therapy, bio-active peptides and recombinant protein with a focus on cancer immunotherapy, angiogenesis, autoimmunity, and inflammatory diseases. He has held positions of increasing responsibility at Chiron (Novartis), Aventis Gencell, Sangstat (Genzyme), BD Biosciences, Progenitor Cell Therapy (NeoStem), and Cellerant.
Tim earned his doctorate in Immunology from the Department of Microbiology & Immunology, UCLA School of Medicine, and completed postdoctoral fellowships at the Salk Institute in La Jolla, CA, and at UC San Diego. Tim also hold an MBA from St. Mary’s College, CA. He is a past member of the Product and Process Development and Immunotherapy Committees, International Society for Cell Therapy, and a member of the American Association of Cancer Research, American Society for Hematology, American Association of Immunologists, and Society for Immunotherapy of Cancer.
Sheila Smith, RN, BSN, HP (ASCP)
Director Clinical Operations
Sheila Smith joined AllCells LLC in July 2014. Sheila brings to AllCells over 30 years of clinical experience with emphasis in therapeutic and donor apheresis, immunology and clinical research. Additional experience include fiscal management, state and federal regulatory compliance, development of standard operating procedures and quality programs.
Prior to joining AllCells, Sheila held the position of Apheresis Regional Manager with Fresenius Medical Care. She was responsible for the operations and clinical oversight of a Northern California mobile apheresis program serving over 65 hospitals and healthcare organizations. Sheila holds a Bachelor of Science in Nursing (Grand Valley State College, Allendale, MI) and a Hemapheresis Practitioner Certification through the American Society for Clinical Pathology.
Director Quality Assurance & Quality Control
Cheryl Covert joined AllCells, LLC in 2017 with more than 25 years of extensive quality management and compliance experience in the FDA-regulated biopharma and medical device industries.
Cheryl started her career at Chiron Corporation, (since acquired by Novartis), holding several positions of increasing responsibility in quality and manufacturing.
In the 10 years prior to joining AllCells, she was head of Quality Assurance for the Clinical Systems Division at Bio-Rad Laboratories.
Ms. Covert directs the quality control and quality assurance processes ensuring AllCells’ Research and Clinical Operations meet applicable domestic and international regulatory requirements.
Cheryl holds a B.S. in Microbiology from San Jose State University and a MBA from St. Mary’s College.